This position is part of the SNSF-funded EMPASTONE Trial (NCT06653738), a multinational, randomized, double-blind, placebo-controlled study evaluating the efficacy of empagliflozin combined with either generic or personalized dietary counselling for the prevention of recurrent calcium kidney stones. The trial is coordinated from Bern and will be conducted across 21 sites in Switzerland, Germany, France and Italy.
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.